Early Intervention in Infants With Unrepaired Cleft Palate: Language, Palatal Function, and Articulation.
NCT ID: NCT07219901
Last Updated: 2025-10-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
200 participants
INTERVENTIONAL
2025-10-21
2027-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Do standard, early intervention techniques to promote language development, that are used in children who are late talkers, work in infants with cleft palates? Will infants with cleft palates increase the number of sounds they use after targeted intervention? Can infants attempt to make stop sounds, like b and p, after targeted intervention? Can infants with cleft palate learn new words more quickly when they are used with gestures?
Participants will:
Participate in a baseline evaluation of speech and language skills, either in person, or via Telehealth.
Attend the clinic for twice-weekly visits, for six weeks, to learn techniques to help their infants develop their speech and language skills, in a group setting with other families of infants with cleft palate.
Participate in a final evaluation of speech and language skills, either in person, or via Telehealth.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Articulation and Phonology in Children With Unilateral Cleft Lip and Palate
NCT00829101
Evaluation of Facial Growth in Two Primary Protocols Used in the Surgical Treatment of Unilateral Cleft Lip and Palate Patients
NCT02329509
An Investigation for the Optimal Timing of a Cleft Palate Repair
NCT00779961
Assessing the Results of Lip Surgery in Patients With Cleft Lip and Palate
NCT00070811
Primary Palatoplasty in Pediatric Patients - A Retrospective Review of Surgical Outcomes
NCT01380171
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants will be caregiver-infant dyads, where the infant is aged between six and twelve months at the time of study enrolment. Infants should be under the current care of a craniofacial team, with no medical diagnosis that would preclude study participation (e.g., reliance on supplementary oxygen, nasopharyngeal airway in situ).
Caregivers
Caregivers should be over the age of 18 years at the time of study enrolment and be able to participate in the group intervention in the English language, although they may speak more than one language or dialect. Individuals who are not able to consent to study participation (due to the presence of a health condition impeding the ability to give consent) will be excluded from this study. Caregivers should identify either as a primary, or joint-primary, caregiver for the infant. Individuals who are not primary caregivers, but who spent a significant amount of time with the infant and who interact with the infant, are also eligible for study participation. There is no limit on the number of caregivers who can attend sessions with their child, to account for non-traditional family structures.
Recruitment
Recruitment will take place at the Cleft and Craniofacial Center of the Children's Hospital of the King's Daughters. Recruitment flyers will be posted in the clinic (see attached recruitment flyer). Families will be invited to participate in the study no more than three times: once between birth and three months of age, at a cleft team meeting; once between three and six months of age at a cleft team meeting, and once again at the six to nine month visit (see attached recruitment script). Families will be invited a maximum of three times, or until first refusal, whichever comes first.
Caregivers will be provided with an information sheet about the study and two consent forms; one for their participation and one for their child's participation. These will be provided by the Surgical Services Unit Research Coordinator (SSURC), at clinic visits. Families will be asked if they would like more information about the study and given a verbal overview of the study and its participation requirements. The SSURC will then leave the clinic room for a brief period to give families time to read the consent forms. On her return, she will ask families if they have any questions, respond to these, and consent families formally, if they are agreeable.
Initial and final evaluations
In order to describe and understand the clinical population, caregivers will be asked to complete the MacArthur-Bates Communicative Development Inventory (MBCDI), which is a measure of understanding and use of words and gestures to communicate, in infants and toddlers aged up to 18 months. This will be the primary, language outcome measure. Additionally, the Rossetti Infant-Toddler Development Scale (RITDS) will be administered by the speech-language pathologist, cooperatively with the caregiver, to describe and understand aspects of communication beyond receptive and expressive language (e.g., pragmatics, attachment). As part of these evaluation sessions, a ten-minute interaction between the infant and the caregiver will be recorded, and a count of communicative behaviors (as outlined in the data sheet) will be made, after the end of the session.
Intervention protocol
The intervention will be delivered face-to-face, in a room in the Lions Child Study Center at Old Dominion University (205). Twelve sessions are planned, with two sessions per week over six weeks; a different topic area, and associated targets, will be selected and focused on each week.
An example, weekly session plans from the intervention protocol are included as an Appendix to this document. It is anticipated that sessions will last for one-hour, and by led by one or more licensed and credentialled speech-language pathologists. The corresponding home carryover handouts are also provided.
Experimental design
This pilot study will be a quasi-experimental, repeated-measures design, where participants serve as their own controls. Baseline data on each outcome measure will be collected at the initial evaluation, prior to commencement of the program, and again at the first group session. Families will be provided with questionnaire measures prior to the appointment, and ten minutes of caregiver-child interactions will be videorecorded for later analysis of outcomes that are measured by behavioral counts. Following the program, an individual, final evaluation and de-brief will be conducted where post-intervention data will be collected. Post-intervention data will be compared against pre-intervention data.
Statistical analysis
Pre- and post-intervention scores will be compared. Statistical test selection will depend on data distribution; although, as this pilot study is anticipated to have a small sample size, it is hypothesized that data will not be distributed normally, thus necessitating the use of non-parametric tests.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
All participants will be allocated to this arm; they will receive the intervention as detailed elsewhere in this protocol.
Early intervention for language, articulation and palatal function skills
This intervention will use the principles of focused stimulation, and enhanced milieu teaching, to coach families in the following speech and language development strategies: attempting oral plosives, increasing phonetic inventory, mapping words to gesture use, and promoting canonical babbling.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Early intervention for language, articulation and palatal function skills
This intervention will use the principles of focused stimulation, and enhanced milieu teaching, to coach families in the following speech and language development strategies: attempting oral plosives, increasing phonetic inventory, mapping words to gesture use, and promoting canonical babbling.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged between 6 and 10 months at the time of study commencement
Exclusion Criteria
* Palatoplasty completed.
* Aged over one year
* Infants with cleft lip only
6 Months
12 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Childrens Hospital of the King's Daughters
UNKNOWN
Old Dominion University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Victoria Reynolds
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Victoria Reynolds, LLB BSc PhD
Role: PRINCIPAL_INVESTIGATOR
Old Dominion University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Old Dominion University
Norfolk, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2355082-5
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.